The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
Open accessAbstract
The major histocompatibility complex (MHC) region is strongly associated with multiple sclerosis (MS) susceptibility. HLA-DRB1*15:01 has the strongest effect, and several other alleles have been reported at different levels of validation. Using SNP data from genome-wide studies, we imputed and tested classical alleles and amino acid polymorphisms in 8 classical human leukocyte antigen (HLA) genes in 5,091 cases and 9,595 controls. We identified 11 statistically independent effects overall: 6 HLA-DRB1 and one DPB1 alleles in class II, one HLA-A and two B alleles in class I, and one signal in a region spanning from MICB to LST1. This genomic segment does not contain any HLA class I or II genes and provides robust evidence for the involvement of a non-HLA risk allele within the MHC. Interestingly, this region contains the TNF gene, the cognate ligand of the well-validated TNFRSF1A MS susceptibility gene. The classical HLA effects can be explained to some extent by polymorphic amino acid positions in the peptide-binding grooves. This study dissects the independent effects in the MHC, a critical region for MS susceptibility that harbors multiple risk alleles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the nature of the interaction may be more complicated than expected, with multiple different amino acid‐level alleles demonstrating consistent interaction with HLA‐DRB1*15:01, in addition to the HLA‐DQA1*01:01 allele.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“the DR15 haplotype and its component alleles also associate with protection against diabetes108, a high risk for multiple sclerosis109,110, and risk or protective effects with many other immune-mediated diseases”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Efron, B., Hastie, T., Johnstone, I., & Tibshirani, R. (2004) · The Annals of Statistics · doi:10.1214/009053604000000067 · Cited by 9,357
A note on a general definition of the coefficient of determination
NAGELKERKE, N. J. D. (1991) · Biometrika · doi:10.1093/biomet/78.3.691 · Cited by 5,927
Regression Shrinkage and Selection via The Lasso: A Retrospective
Tibshirani, R. J. (2011) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2011.00771.x · Cited by 3,601
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
ChromHMM: automating chromatin-state discovery and characterization
Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,457
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 311
Burnard, S. M., Lea, R. A., Benton, M. C., Eccles, D., Kennedy, D. W., Lechner‐Scott, J., & Scott, R. J. (2021) · Genes · doi:10.3390/genes13010087 · Cited by 4
Goodin, D. S., Khankhanian, P., Gourraud, P., & Vince, N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285599 · Cited by 6
Self-citationGenetics of Multiple Sclerosis
Oksenberg, J. R., & McCauley, J. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00004-0 · Cited by 4
Self-citationYau, A. C. Y., Tuncel, J., & Holmdahl, R. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.022 · Cited by 4
Roostaei, T., & Jager, P. L. D. (2019) · Current clinical neurology · doi:10.1007/978-3-030-24436-1_4 · Cited by 4
Linking Genotype to Clinical Phenotype in Multiple Sclerosis
Longbrake, E. E., & Hafler, D. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1227 · Cited by 4
Self-citationXavier, A., Maltby, V. E., Ewing, E., Campagna, M. P., Burnard, S. M., Tegner, J. N., Slee, M., Butzkueven, H., Kockum, I. S., Kular, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2570500/v1 · Cited by 4
Self-citationYan, F., Wu, T. T., Meng, Q., & Qu, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320304 · Cited by 3
Epidemiological studies of Epstein-Barr virus and associated diseases
Cao, S., Ji, M., He, Y., & Jia, W. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0191 · Cited by 3
Santoro, S., Clarelli, F., Preziosa, P., Storelli, L., Cannizzaro, M., Mascia, E., Esposito, F., Rocca, M. A., & Filippi, M. (2022) · Genes · doi:10.3390/genes13112136 · Cited by 3
Asgari, N., Ghaemi, E. A., Naeimi, M. H., Tahamtan, A., Sechi, L. A., & Zamani, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22137 · Cited by 3
Role of Genetic Factors in Pathophysiology of Multiple Sclerosis
Goris, A., Dubois, B., & Hilven, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00008-7 · Cited by 3
Pisapia, L., Cerillo, I., Farina, F., Zimbardo, A., Barba, P., Orefice, G., Gianfrani, C., Strazzullo, M., & Pozzo, G. D. (2019) · International Journal of Immunogenetics · doi:10.1111/iji.12450 · Cited by 3
Namgoong, S., Bae, J. S., Cheong, H. S., Kim, J. H., Kim, J. Y., Kim, L. H., Kim, H. J., & Shin, H. D. (2014) · Tissue Antigens · doi:10.1111/tan.12358 · Cited by 3
Goodin, D. S., Khankhanian, P., Gourraud, P., & Vince, N. (2020) · Research Square · doi:10.21203/rs.3.rs-77060/v1 · Cited by 3
Self-citationA Genetically Driven Immunologic Mechanism Underlying the Link between EBV and Multiple SclerosisPreprint
Yasumizu, Y., Kim, N., Rivier, C. A., Moon, J., Kojima, S., CHEN, H.-L., Buitrago-Pocasangre, N., Silberfeld, A., Quinn, E., Vaughn, S., et al. (2025) · medRxiv · doi:10.64898/2025.12.11.25342083 · Cited by 3
Self-citationZhang, S., Yao, Y., Li, Y., Zhang, X., & Wu, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04985-4 · Cited by 2
Jiao, S., Bao, L., Lu, X., Wu, Y., & Li, Y. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07209-0 · Cited by 2
Corsten, C. E. A., Marques, A. M., Masmanidou, D., Ikram, M. K., van Luijn, M. M., Wokke, B. H. A., & Smolders, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-17254-0 · Cited by 2
Alatawi, Z. (2025) · Developmental Neurobiology · doi:10.1002/dneu.23014 · Cited by 2
Mesenchymal stem cells and the central nervous system: historical perspectives and future directions
Mazurek, C. Y., Kaniuk, J. K., & Ahuja, C. S. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1742864 · Cited by 2
An Accurate Genetic Colocalisation Method for the HLA Locus
Butler‐Laporte, G., Lu, T., Morris, S., Zhang, W., Band, G., Hamilton, F., Chong, A. Y.-Y., Lin, K., Nanjala, R., Richards, J. B., et al. (2026) · HLA · doi:10.1111/tan.70759 · Cited by 7
Rau, C. N., Severin, M. E., Lee, P. W., Deffenbaugh, J. L., Liu, Y., Murphy, S. P., Petersen‐Cherubini, C. L., & Lovett‐Racke, A. E. (2024) · European Journal of Immunology · doi:10.1002/eji.202350548 · Cited by 2
MHConstructor: a high-throughput, haplotype-informed solution to the MHC assembly challenge
Wade, K. J., Suseno, R., Kizer, K., Williams, J. P., Boquett, J. A., Caillier, S. J., Pollock, N. R., Renschen, A., Santaniello, A., Oksenberg, J. R., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03412-6 · Cited by 2
Self-citationFukaura, H. (2014) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/1/1/1007 · Cited by 2
Ye, L., Yang, C., Dou, J., Wen, L.-L., Wang, W., Zheng, X., Zuo, X., Zhou, F., Fan, X., & Zhang, X. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2997 · Cited by 2
Genetics of Multiple Sclerosis
Alcina, A., Fedetz, M., & Matesanz, F. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-03934-9_10 · Cited by 2
Physiopathologie de la sclérose en plaques : actualités
Lubetzki, C. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.03.006 · Cited by 6
Immunogenetic mechanism driving neurological and neurodegenerative disorders
Hajam, Y. A., Premlata, P., Rani, R., Sharma, R., Sharma, P., & Kumar, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00001-7 · Cited by 2
Jager, P. L. D. (2012) · Wiley eBooks · doi:10.1002/9781119963714.ch3 · Cited by 2
The Immunobiology of Multiple Sclerosis
Olsson, T. P., & Piehl, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.15007-6 · Cited by 2
Self-citationGoodin, D. S., Khankhanian, P., Gourraud, P., & Vince, N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/603878 · Cited by 2
Self-citationGenetic Factors in Neuroimmune Diseases
Didonna, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_11-1 · Cited by 1
Faust, M. A., Gibbs, L. C., Oviedo, J. M., Cornwall, D. H., Fairfax, K. C., Zhou, Z., Lamb, T. J., & Evavold, B. D. (2024) · ImmunoHorizons · doi:10.4049/immunohorizons.2400069 · Cited by 1
Interplay between the host genome, autoimmune disease and infection
Martin, M., Sanchiz, Á., & Navasa, N. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.02.006 · Cited by 1
Immunogenetics of Multiple Sclerosis in Romanian Patients: Preliminary Data
Constantinescu, A. E., Mărunțelu, I., Pleșa, A., Sîrbu, C. A., Pleşa, C., Constantinescu, A. I., & Constantinescu, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157628 · Cited by 1
Bajcsi, D., Maróti, Z., Endreffy, E., Légrády, P., Ábrahám, G., & Iványi, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178621 · Cited by 1
Laitinen, A. W., Tozlu, C., Roostaei, T., Diallo, F., Onomichi, K. B., Son, J., Xia, Z., & Jager, P. L. D. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70340 · Cited by 2
Targeting progressive multiple sclerosis: Toward mechanism‐informed precision medicine
Piehl, F., Castelo‐Branco, G., Jagodic, M., & Olsson, T. P. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70125 · Cited by 1
Self-citationGenetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions
He, J., Blackburn, N. B., & Jokubaitis, V. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-01009-8 · Cited by 1
The use of haplotype-specific transcripts improves sample annotation consistency
Hartmann, N., Luesink, E. J., Khokhlovich, E., Szustakowski, J. D., Bäriswyl, L., Peterson, J. C., Scherer, A., Nirmala, N., & Staedtler, F. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-17 · Cited by 1
Studies of risk loci in multiple sclerosis
Lindén, M. (2014) · Cited by 1
Kimbrough, D. J., & Braley, T. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804074-4.00009-1 · Cited by 1
Genetic Factors in Neuroimmune Diseases
Didonna, A., & Cantó, E. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_11 · Cited by 1
Detecting Genetic Disposition of Ethnicity to Autoimmune Diseases via Clustering
Senturk, D., & Orman, G. K. (2021) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata52589.2021.9671698 · Cited by 1
Epidemiology, epigenetics, and etiological factors in multiple sclerosis
Beard, K., Srivastava, S., Sharma, K., Jaiswal, S., Reddy, S. P., Lisak, R. P., & Sriwastava, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95343-6.00005-4 · Cited by 1
Genetics of Multiple Sclerosis
Abulaban, A. A., Hafler, D. A., & Longbrake, E. E. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00033 · Cited by 1
Self-citationNeurological manifestations similar to multiple sclerosis in adults after Zika virus infection
Alves‐Leon, S. V., Fontes-Dantas, F. L., & Lopes, F. C. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820268-5.00018-3 · Cited by 1
Shehab, M. M. (2021) · Archives in Neurology & Neuroscience · doi:10.33552/ann.2021.10.000750 · Cited by 1
Carotenuto, A., Iodice, R., & Arcara, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-74985-9_16 · Cited by 1
Ploumakis, A., Weiner, H. L., & Patsopoulos, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00016-2 · Cited by 1
Self-citationMultiple Sclerosis Progression: a clinical, genetic, and environmental investigation
George, M. F. (2014) · eScholarship (California Digital Library) · Cited by 1
Cunniffe, N. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.77136 · Cited by 1
Butler‐Laporte, G., Farjoun, Y., Nakanishi, T., Lu, T., Abner, E., Chen, Y., Hultström, M., Metspalu, A., Milani, L. A., Mägi, R., et al. (2023) · medRxiv · doi:10.1101/2023.01.15.23284570 · Cited by 1
Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgroundsPreprint
Jacobs, B. M., Schalk, L., Tregaskis-Daniels, E., Scalfari, A., Nandoskar, A., Dunne, A., Gran, B., Mein, C. A., Sellers, C., Spilker, C., et al. (2025) · medRxiv · doi:10.1101/2025.01.16.25320672 · Cited by 1
Self-citationGENETIC AND EPIGENETIC FACTORS SHAPING THE TRANSCRIPTOME IN MULTIPLE SCLEROSIS AND ITS ANIMAL MODEL
Bergman, P. (2014) · Figshare
Genetic studies of complex autoimmune disease
Gyllenberg, A. (2014) · Figshare
Innate immunity in progressive multiple sclerosis
Aeinehband, S. (2015) · Figshare
Advance of genetics in multiple sclerosis
Matsushita, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12275
Carmichael, D. A. (2015) · ERA
Local joint testing improves power and identifies missing heritability in association studiesPreprint
Brown, B. C., Price, A. L., Patsopoulos, N. A., & Zaitlen, N. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/040089
Self-citationMistry, N. (2016) · Apollo (University of Cambridge) · doi:10.17863/cam.6132
Genetic and molecular studies of multiple sclerosis associated genes
Keshari, P. (2017) · NORA - Norwegian Open Research Archives
Hill, A. M. (2017) · UCL Discovery (University College London)
Computational approaches to understanding the genetic architecture of complex traits
Brown, B. C. (2016) · UC Berkeley
The Association of Genetic Factors to Multiple Sclerosis Susceptibility
Seyedsadr, M., & Dashti, S. (2018) · Journal of Human Genetics and Genomics · doi:10.5812/jhgg.87043
Épidémiologie, environnement et génétique dans la sclérose en plaques
Defer, G. L., Debouverie, M., Bardou, I., Benamar, M., Bernard‐Valnet, R., Branger, P., Brassat, D., Benallegue, N., Calocer, F., Damotte, V., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00002-1
Guo, J., Zhang, T., Li, X., Cao, H., & Li, Z. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217064
Schonewille, H., van de Watering, L. M. G., Oepkes, D., Lopriore, E., Cobbaert, C. M., & Brand, A. (2020) · Vox Sanguinis · doi:10.1111/vox.12941
Applications of Cutting-Edge Immunoproteomics Technology in Human Immunotherapy
Comber, J. D., & Philip, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_2
Immune regulation by mimethyl fumarate (DMF) in relapsing-remitting multiple sclerosis patients
Diaz, G. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201015gmd
Astrocytes in the pathogenesis of multiple sclerosis
Takarada‐Iemata, M., & Hori, O. (2021) · Folia Pharmacologica Japonica · doi:10.1254/fpj.21030
Hernández, D. (2013) · Energía de hoy.com
Immunogenetic surveillance to histocompatibility
Sheikh, W. M., Ali, S. I., Rather, M. A., Nabi, S. U., Nazir, S. U., Rakshahan, R., & Bashir, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00010-5
Multiple sclerosis following multiple endocrine neoplasia type 2: A case report
Sedighi, B., Gozashti, M. H., Akbari, Z., Shafie’ei, M., & Abna, Z. (2022) · Neuroimmunology Reports · doi:10.1016/j.nerep.2022.100080
Multiple Sclerosis: Exploring the Limits of Genetic and Environmental SusceptibilityPreprint
Goodin, D. S., Khankhanian, P., Gourraud, P., & Vince, N. (2022) · medRxiv · doi:10.1101/2022.03.09.22272129
Self-citationFaculty Opinions recommendation of An atlas of genetic associations in UK Biobank.
Ko, D. C. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734266796.793559201
Jia, X., Baranzini, S. E., & Hauser, S. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00018-7
Lim, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737542494.793577703
Neuroinflammation in Multiple Sclerosis
Prasad, P., Roth, L., Ionescu, R.-B., Willis, C. M., Nicaise, A. M., Krzak, G., Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00267-4
Influence of Epstein-Barr virus infection on developing multiple sclerosis
OŁOWNIA, A., Orczyk, J., & Kozioł, M. M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.22.01.004
The initial symptoms in multiple sclerosis: clinical and demographic data of Çorum province
Eliaçık, S., & Aykaç, S. (2023) · Anatolian Current Medical Journal · doi:10.38053/acmj.1323204
Barjui, S. P., Shahrakei, Z. F., & Jivad, N. (2023) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26068
Genetic alterations leading to autoimmunity
Tessneer, K. L., Kelly, J. A., & Gaffney, P. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00026-6
Link Between PTSD and Autoimmune Diseases: A Path to Effective Treatment. Literature review
Kajka, A., Antczak, J., Wojtczak, K., Lipska, J., Fenrych, U., Hamerska, L., Hamerska, J., Bocianiak, B., Ruta, D., & Skupińska, O. (2024) · Quality in Sport · doi:10.12775/qs.2024.20.53147
Astrocyte Reprogramming by Th17 Cells in Autoimmune Neuroinflammation: Mechanisms and Implications
Milne, S. M. (2024) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12577
Associations of classical HLA alleles with sleep behaviours
Zhou, R., Cheng, B., Wei, W., Gou, Y., Hui, J., Kang, M., Liu, C., Liu, Y., Shi, P., Wang, B., et al. (2024) · HLA · doi:10.1111/tan.15658
Genetic Factors in Neuroimmune Diseases
Didonna, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_11
The immunology and pathophysiology of multiple sclerosis
Saez-Calveras, N., & Stüve, O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00020-4
Reijm, S., Marques, A. M., Rip, J., Corsten, C. E. A., Wierenga‐Wolf, A. F., de Wit, H., Melief, M., van Hasselt, Y., van Langelaar, J., Neuteboom, R. F., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115744 · Cited by 1
The Immunobiology of Multiple Sclerosis
Ruffin, N., Piehl, F., & Olsson, T. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00271-4
Self-citationMimicry in the Bite: Shared Sequences Between Aedes aegypti Salivary Proteins and Human Proteins
Arévalo-Cortés, A., & Rodriguez-Pinto, D. (2025) · Proteomes · doi:10.3390/proteomes13040056
Kachuri, L., Francis, S. S., Morrison, M. L., Wendt, G. A., Bossé, Y., Cavazos, T. B., Rashkin, S. R., Ziv, E., & Witte, J. S. (2020) · Figshare · doi:10.6084/m9.figshare.13152376
Kachuri, L., Francis, S. S., Morrison, M. L., Wendt, G. A., Bossé, Y., Cavazos, T. B., Rashkin, S. R., Ziv, E., & Witte, J. S. (2020) · Figshare · doi:10.6084/m9.figshare.13152379
Multiscale Modelling of Multiple Sclerosis Initiation and ProgressionPreprint
Hillen, T., & Jenner, A. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.04.697229
Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis
Kuiper, K. L., Bogers, L., Rip, J., van Hasselt, Y., Melief, M., Wierenga‐Wolf, A. F., Kranenbarg, R. A. M. K., Bindels, E. M., van de Werken, H. J. G., de Beukelaar, J., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200553
Corsten, C. E. A., Marques, A. M., van Hasselt, Y., van Rooij, J., Smets, I., van Luijn, M. M., Neuteboom, R. F., Wokke, B. H. A., & Smolders, J. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107101
The genetic architecture of multiple sclerosis in 2026: From susceptibility to disease progression
Bourguiba, S., Paris, J., Gourraud, P., & Vince, N. (2026) · Revue Neurologique · doi:10.1016/j.neurol.2026.03.006
Self-citation
Metadata
- Authors
- Patsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., van Duijn, C. M., Noble, J. A., Raj, T., IMSGC, ANZgene, Gourraud, P.-A., Stranger, B. E., Oksenberg, J., Olsson, T., Taylor, B. V., Sawcer, S., Hafler, D. A., Carrington, M., De Jager, P. L., & de Bakker, P. I. W.
- Affiliations
- Broad Institute (US)
- Kaiser Permanente (US)
- Erasmus MC (NL)
- University of California, San Francisco (US)
- University of Chicago (US)
- Karolinska Institutet (SE)
- University of Tasmania (AU)
- University of Cambridge (GB)
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-21
- Volume
- 9
- Issue
- 11
- Pages
- e1003926
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3836799
- OpenAlex
- W2164021954
- Cited by
- 312
- References
- 50
- Citations by year
- 2026: 19 · 2025: 14 · 2024: 23 · 2023: 19 · 2022: 17 · 2021: 32 · 2020: 30 · 2019: 32 · 2018: 26 · 2017: 21 · 2016: 27 · 2015: 28 · 2014: 22 · 2013: 1
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Genetics (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (acceptedVersion, other-oa)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- eCite Digital Repository (University of Tasmania) (submittedVersion, public-domain)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Murdoch University Research Portal (submittedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, public-domain)
- Figshare (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- University of Chicago
- Funders
- U.S. Department of Health and Human Services (HHSN261200800001E)
- National Multiple Sclerosis Society (JF2138A1)
- John T. Reid Charitable Trusts
- Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
- National Institute for Health and Care Research (NF-SI-0508-10335)
- Multiple Sclerosis Society
- Multiple Sclerosis Australia
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.126.354)
- Stockholms Läns Landsting (562183)
- Vetenskapsrådet
- Trish Multiple Sclerosis Research Foundation
- National Institutes of Health (Contract No. HHSN261200800001E., #HHSN261200800001E, HHSN261200800001C)
- U.S. Public Health Service (NIH/NIAID R01AI076544)
- Australian Research Council (LP0776744)
- National Cancer Institute (HHSN261200800001E))
- National Institute of Allergy and Infectious Diseases (HHSN261200800001E, R01AI076544)
- National Institute of Neurological Disorders and Stroke (R01 NS0495103, R01NS026799, R01NS049510, NIH/NINDS R01NS049510, R01NS049477)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, major histocompatibility complex, HLA-DRB1*1501, TNF-α, TNFRSF1A, disease susceptibility, fine mapping
- MeSH terms
- Alleles, Chromosome Mapping, Haplotypes, Humans, Major Histocompatibility Complex, Membrane Proteins, Multiple Sclerosis, Histocompatibility Antigens Class I, Linkage Disequilibrium, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptors, Tumor Necrosis Factor, Type I, Intracellular Signaling Peptides and Proteins, Genome-Wide Association Study, HLA-DRB1 Chains, HLA-DP beta-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
